Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 49 publications
Prescribed medical cannabis in women with gynecologic malignancies: A single-institution survey-based study.
Journal: Gynecologic oncology reports
Published: September 01, 2020
Outcomes and relapse patterns of stage IB grade 2 or 3 endometrial cancer treated with adjuvant vaginal brachytherapy.
Journal: International journal of gynecological cancer : official journal of the International Gynecological Cancer Society
Published: June 14, 2019
Impact of carboplatin hypersensitivity and desensitization on patients with recurrent ovarian cancer.
Journal: Journal of cancer research and clinical oncology
Published: August 22, 2018
Adjuvant Hormonal Therapy for Low-Grade Endometrial Stromal Sarcoma.
Journal: Reproductive sciences (Thousand Oaks, Calif.)
Published: May 31, 2018
When Things Go Wrong: Examining the Frequency and Aftermath of Critical Incidents Among OBGYN Residents.
Journal: Connecticut medicine
Published: May 09, 2018
Ten-Year Comparison Study of Type 1 and 2 Endometrial Cancers: Risk Factors and Outcomes.
Journal: Gynecologic and obstetric investigation
Published: April 10, 2018
Associated characteristics and impact on recurrence and survival of free-floating tumor fragments in the lumen of fallopian tubes in Type I and Type II endometrial cancer.
Journal: Gynecologic oncology reports
Published: October 24, 2017
The use of QuikClot combat gauze in cervical and vaginal hemorrhage.
Journal: Gynecologic oncology reports
Published: April 29, 2017
Superior in vitro and in vivo activity of trastuzumab-emtansine (T-DM1) in comparison to trastuzumab, pertuzumab and their combination in epithelial ovarian carcinoma with high HER2/neu expression.
Journal: Gynecologic oncology
Published: April 19, 2017
The management of sexuality, intimacy, and menopause symptoms (SIMS) after prophylactic bilateral salpingo-oophorectomy: How to maintain sexual health in "previvors".
Journal: Maturitas
Published: March 30, 2017
Efficacy of neratinib in the treatment of HER2/neu-amplified epithelial ovarian carcinoma in vitro and in vivo.
Journal: Medical oncology (Northwood, London, England)
Published: March 13, 2017
SYD985, a novel duocarmycin-based HER2-targeting antibody-drug conjugate, shows promising antitumor activity in epithelial ovarian carcinoma with HER2/Neu expression.
Journal: Gynecologic oncology
Published: February 20, 2017
Last Updated: 09/26/2026